erythromycin has been researched along with Rhinitis, Allergic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY; Jiang, RS; Liang, KL; Wu, CY; Yen, TT | 1 |
1 other study(ies) available for erythromycin and Rhinitis, Allergic
| Article | Year |
|---|---|
Erythromycin reduces nasal inflammation by inhibiting immunoglobulin production, attenuating mucus secretion, and modulating cytokine expression.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Cytokines; Dexamethasone; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Immunoglobulin E; Male; Mice, Inbred BALB C; Middle Aged; Mucus; Nasal Mucosa; Rhinitis, Allergic; Sinusitis; Young Adult | 2021 |